Fougera, a division of ALTANA Inc Company Profile

03:57 EDT 22nd June 2018 | BioPortfolio

The philosophy embraced by Fougera’s founders more than 150 years ago still holds true today - “to deliver value and reliability.” Since first entering the generic market in 1966, Fougera, a division of ALTANA Inc, has become one of the largest manufacturers, marketers and distributors of a wide range of multi-source topicals and ophthalmics in both prescription and over-the-counter dosage forms.
During the past five years, no other company has received as many FDA approvals for topical products as Fougera - and their momentum is just beginning. Fougera maintains a steadfast commitment to new product development and prides itself on introducing only the highest quality generic products to the market. Just visit the company’s what’s new section for a preview of recent product introductions.
Fougera’s high standards mirror your own. A meticulous attention to detail permeates every phase of the company’s operation, from selection of ingredients, product formulation and manufacturing, to distribution and customer service.
Not all generic companies are created equal. By selecting a Fougera product, you are guaranteed the pinnacle of product quality, reliability and consistency, backed by the best customer service in the business.


New York
United States of America



News Articles [168 Associated News Articles listed on BioPortfolio]

Mediclinic nudges up guidance after strong second half for its Middle East division

The turnaround at the Middle East division is progressing well while the Swiss division, which was affected by regulatory changes, is performing in line. The South African division saw second-half rev...

SAS creates new division to fight fraud globally with AI and advanced analytics

The division will further focus and sharpen the SAS fraudand cybersecurityportfolio. More than 400 employees in 25 countries across the Americas, Europeand Read more...

Telit Communications says numerous parties interested in automotive division

Internet of Things enabler Telit Communications noted press speculation regarding the sale of its automotive division and said it has received interest from "numerous" parties and a range of proposals...

Medifirst Solutions Forms Specialty Prescription Billing & Pharmacy Solutions Division

Medifirst Solutions, a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, is pleased to announce that it has laun...

UNIGE researchers discover why premature cell division promotes tumor formation

The accumulation of mutations in the human genome is at the origin of cancers, as well as the development of resistance to treatments. The Cyclin E and Myc genes are active in the control of cell divi...

Public-private partnership division launched by BARDA

The four-entity Division of Research, Innovation and Ventures has been launched by HHS's Biomedical Advanced Research Develop -More- 

New 'religious freedom' division sows fears of LGBTQ discrimination

Health and Human Services' creation of a Conscience and Religious Freedom Division is being seen by many as a "license to discriminate."

Siemens starts IPO process for medtech division

An Intention to Float has been published by Siemens as it prepares for an initial public offering of its medtech division, Si -More- 

Drugs and Medications [400 Associated Drugs and Medications listed on BioPortfolio]

Triple antibiotic [E. FOUGERA & CO., A division of Nycomed US Inc.]

Fougera Triple Antibiotic Ointment(Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ointment USP)

Bacitracin zinc [E. FOUGERA & CO., A division of Nycomed US Inc.]

Bacitracin Zinc Ointment USP

Double antibiotic [E. FOUGERA & CO., A division of Nycomed US Inc.]

Fougera Double Antibiotic Ointment(Bacitracin Zinc and Polymyxin B Sulfate Ointment USP)

Urea [E. FOUGERA & CO., A division of Nycomed US Inc.]

UREA LOTION 35%In a vehicle containing vitamin E, lactic acid and zinc

Urea [E. FOUGERA & CO., A division of Nycomed US Inc.]

UREA 50% EMULSION          Rx only

PubMed Articles [267 Associated PubMed Articles listed on BioPortfolio]

An overview of plant division-plane orientation.

Contents Summary 1 I. Introduction 1 II. Models of plant cell division 1 III. Establishing the division plane 2 IV. Maintaining the division plane during mitosis and cytokinesis 5 Acknowledgements 6 R...

Small molecule chelators reveal that iron starvation inhibits late stages of bacterial cytokinesis.

Bacterial cell division requires identification of the division site, assembly of the division machinery, and constriction of the cell envelope. These processes are regulated in response to several ce...

Research progress on the asymmetric division in mammalian oocytes.

The mammalian oocyte maturation process consists of two consecutive asymmetric divisions, and produces three daughter cells of vastly different sizes: one larger egg cell and two smaller polar bodies....

Src activation decouples cell division orientation from cell geometry in mammalian cells.

Orientation of cell division plane plays a crucial role in morphogenesis and regeneration. Misoriented cell division underlies many important diseases, such as cancer. Studies with Drosophila and C. e...

Tuning Division and Differentiation in Stomata: How to Silence a MUTE.

Precise coordination of cell differentiation and division within a tissue context is critical for plant development. In this issue of Developmental Cell, Han et al. (2018) report a transcriptional sw...

Clinical Trials [145 Associated Clinical Trials listed on BioPortfolio]

Division-less Gastric Bypass, Step to Decrease Cost and Early Nightmare of Bariateric Surgery

The purpose of this study is to determine the efficacy of of gastric bypass without gastric division as a treatment for morbid obesity

TMJ Adaptations by Orthodontic Treatment in Adolescent Males With Angle's Class II Division 2 Malocclusion: MRI Study

the aim of this study is to document the changes brought about in the internal anatomic relationships of the TMJ complex , positional changes of glenoid fossa with respect to adjacent cran...

Comparison of Hip Range of Motion Values Among NCAA Division II Collegiate Athletes

The purpose of this study is to compare hip passive range of motion (ROM) among division II collegiate athletes in order to obtain normative data for future research. The investigators hyp...

Comparative Evaluation of PowerScope and Forsus

The objective of this 2-arm parallel double blinded randomized controlled trial is was to evaluate and compare the treatment effects of PowerScope and Forsus in the treatment of Class II d...

Hemochromatosis and Iron Overload Screening Study (HEIRS)

To determine the prevalence, genetic and environmental determinants, and potential clinical, personal, and societal impact of iron overload and hereditary hemochromatosis, in a multi-cente...

Companies [738 Associated Companies listed on BioPortfolio]

Altana Incorporated

ALTANA INC. is comprised of three divisions. E. Fougera & Company is a generic drug division which produces mainly topical ointments and creams. It is one of the largest manufacturers and distributor...

Fougera, a division of ALTANA Inc

The philosophy embraced by Fougera’s founders more than 150 years ago still holds true today - “to deliver value and reliability.” Since first entering the generic market in 1966, Fougera, a div...


Founded in 1849, Fougera is a division of Nycomed US Inc. and is the leading manufacturer and distributor of a wide range of topical products. For more information on Fougera's complete line of produc...


ALTANA Inc. is the parent corporation for four New York based divisions of ALTANA Pharma AG: E. Fougera & Company, Savage Laboratories, PharmaDerm and Pharmaderm Animal Health. ALTANA Pharma AG, an in...

Nycomed US Inc.

Nycomed US Inc. is a subsidiary of Nycomed and operates three divisions in the United States focused on specialty pharmaceuticals in dermatology. Founded in 1849, Fougera is a division of Nycomed US ...

More Information about "Fougera, a division of ALTANA Inc" on BioPortfolio

We have published hundreds of Fougera, a division of ALTANA Inc news stories on BioPortfolio along with dozens of Fougera, a division of ALTANA Inc Clinical Trials and PubMed Articles about Fougera, a division of ALTANA Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fougera, a division of ALTANA Inc Companies in our database. You can also find out about relevant Fougera, a division of ALTANA Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Corporate Database Quicklinks

Searches Linking to this Company Record